USX:CAPS - Capstone Therapeutics Corp Capstone Therapeutics Corp
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 36.01    +0.0 (+0%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

23 Jul 2021


Loading...
Loading...
Loading...

General

CEO: Mr. Michael M. Toporek

IPO: 1993-01-28

Headquarters: US

Employees: 0

Homepage

Description

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.